These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 17351902)

  • 1. RNAse A-like enzymes in serum inhibit the anti-neoplastic activity of siRNA targeting polo-like kinase 1.
    Haupenthal J; Baehr C; Zeuzem S; Piiper A
    Int J Cancer; 2007 Jul; 121(1):206-10. PubMed ID: 17351902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Silencing of polo-like kinase (Plk) 1 via siRNA causes induction of apoptosis and impairment of mitosis machinery in human prostate cancer cells: implications for the treatment of prostate cancer.
    Reagan-Shaw S; Ahmad N
    FASEB J; 2005 Apr; 19(6):611-3. PubMed ID: 15661849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Small interfering RNA library screen identified polo-like kinase-1 (PLK1) as a potential therapeutic target for breast cancer that uniquely eliminates tumor-initiating cells.
    Hu K; Law JH; Fotovati A; Dunn SE
    Breast Cancer Res; 2012 Feb; 14(1):R22. PubMed ID: 22309939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Influence of silencing Polo-like kinase 1 on migration and invasion of colorectal cancer cells].
    Han DP; Cui JT; Lu AG; Chen XH; Feng B; Zong YP; Qu S; Cao QF; Zheng MH
    Zhonghua Wei Chang Wai Ke Za Zhi; 2011 Jan; 14(1):61-4. PubMed ID: 21271384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rational combinations of siRNAs targeting Plk1 with breast cancer drugs.
    Spänkuch B; Kurunci-Csacsko E; Kaufmann M; Strebhardt K
    Oncogene; 2007 Aug; 26(39):5793-807. PubMed ID: 17369857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improvement of doxorubicin efficacy using liposomal anti-polo-like kinase 1 siRNA in human renal cell carcinomas.
    Sakurai Y; Hatakeyama H; Akita H; Harashima H
    Mol Pharm; 2014 Aug; 11(8):2713-9. PubMed ID: 24800640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic targeting of polo-like kinase 1 using RNA-interfering nanoparticles (iNOPs) for the treatment of non-small cell lung cancer.
    McCarroll JA; Dwarte T; Baigude H; Dang J; Yang L; Erlich RB; Kimpton K; Teo J; Sagnella SM; Akerfeldt MC; Liu J; Phillips PA; Rana TM; Kavallaris M
    Oncotarget; 2015 May; 6(14):12020-34. PubMed ID: 25557168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficient inhibition of human colorectal carcinoma growth by RNA interference targeting polo-like kinase 1 in vitro and in vivo.
    Xu WJ; Zhang S; Yang Y; Zhang N; Wang W; Liu SY; Tian HW; Dai L; Xie Q; Zhao X; Wei YQ; Deng HX
    Cancer Biother Radiopharm; 2011 Aug; 26(4):427-36. PubMed ID: 21797676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Small interfering RNA-mediated Polo-like kinase 1 depletion preferentially reduces the survival of p53-defective, oncogenic transformed cells and inhibits tumor growth in animals.
    Guan R; Tapang P; Leverson JD; Albert D; Giranda VL; Luo Y
    Cancer Res; 2005 Apr; 65(7):2698-704. PubMed ID: 15805268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of anti-PLK1 siRNA-containing F3-targeted liposomes on the viability of both cancer and endothelial cells.
    Gomes-da-Silva LC; Ramalho JS; Pedroso de Lima MC; Simões S; Moreira JN
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):356-64. PubMed ID: 23659854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Silencing of polo-like kinase (Plk) 1 via siRNA causes inhibition of growth and induction of apoptosis in human esophageal cancer cells.
    Bu Y; Yang Z; Li Q; Song F
    Oncology; 2008; 74(3-4):198-206. PubMed ID: 18714168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenous liposomal delivery of the short hairpin RNAs against Plk1 controls the growth of established human hepatocellular carcinoma.
    Deng H; Jiang Q; Yang Y; Zhang S; Ma Y; Xie G; Chen X; Qian Z; Wen Y; Li J; Yang J; Chen L; Zhao X; Wei Y
    Cancer Biol Ther; 2011 Feb; 11(4):401-9. PubMed ID: 21150280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Knockdown of PLK1 mRNA by special siRNA].
    Chen GX; Dong QH; Zhang JW; Fu FF; Xu ZF; Liang QY; Zheng S; Ding JY
    Yi Chuan; 2006 Jan; 28(1):21-5. PubMed ID: 16469711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Downregulation of Polo-like kinase 1 induces cellular senescence in human primary cells through a p53-dependent pathway.
    Kim HJ; Cho JH; Kim JR
    J Gerontol A Biol Sci Med Sci; 2013 Oct; 68(10):1145-56. PubMed ID: 23525475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid functional screening of effective siRNAs against Plk1 and its growth inhibitory effects in laryngeal carcinoma cells.
    Lan H; Zhu J; Ai Q; Yang Z; Ji Y; Hong S; Song F; Bu Y
    BMB Rep; 2010 Dec; 43(12):818-23. PubMed ID: 21189159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Enhancive effect of PLK1 gene silencing on sensitivity of K562/A02 cells to adriamycin].
    Liu L; Zhang M; Zou P; Tian L; Liu F
    Ai Zheng; 2006 Apr; 25(4):404-8. PubMed ID: 16613670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Study of growth inhibition of gastric cancer cells by sRNA targeting polo like kinase 1 in vitro and vivo].
    Lan B; Liu BY; Cheng XH; Qu Y; Zhang XQ; Cai Q; Dai QB; Zhu ZG
    Zhonghua Wai Ke Za Zhi; 2006 Jan; 44(1):40-4. PubMed ID: 16620646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphorylation of TCTP as a marker for polo-like kinase-1 activity in vivo.
    Cucchi U; Gianellini LM; De Ponti A; Sola F; Alzani R; Patton V; Pezzoni A; Troiani S; Saccardo MB; Rizzi S; Giorgini ML; Cappella P; Beria I; Valsasina B
    Anticancer Res; 2010 Dec; 30(12):4973-85. PubMed ID: 21187478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Inhibition of polo like kinase gene expression induces apoptosis in gastric cancer cells].
    Lan B; Liu BY; Cheng XH; Qu Y; Zhang XQ; Cai Q; Zhu ZG
    Zhonghua Wei Chang Wai Ke Za Zhi; 2006 Jan; 9(1):62-6. PubMed ID: 16437376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicopathological significance of Polo-like kinase 1 (PLK1) expression in human malignant glioma.
    Cheng MW; Wang BC; Weng ZQ; Zhu XW
    Acta Histochem; 2012 Sep; 114(5):503-9. PubMed ID: 22000864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.